CME : 1Q 2026 Income Statement Trend

Published: 2026-04-22 07:24:09 ET CME

Published on 04/22/2026 at 07:24 am EDT

CONSOLIDATED STATEMENTS OF GAAP INCOME

QUARTER ENDED

(dollars in millions, except per share data; shares in thousands)

Q124

Q224

Q324

Q424

Q125

Q225

Q325

Q425

Q126

Revenues:

Clearing and transaction fees

1,208.9

1,249.9

1,297.1

1,232.3

1,337.3

1,388.0

1,227.9

1,327.9

1,542.6

Market data and information services

175.4

175.0

178.2

181.6

194.5

198.1

202.5

208.0

224.1

Other Revenue

103.6

107.6

109.1

111.4

110.5

105.9

107.2

112.8

113.4

Total revenues

1,487.9

1,532.5

1,584.4

1,525.3

1,642.3

1,692.0

1,537.6

1,648.7

1,880.1

Expenses:

Compensation and benefits

206.0

204.7

218.8

220.8

206.7

221.6

237.6

241.1

223.0

Technology

59.4

64.1

66.6

65.7

70.9

71.4

75.2

76.6

Professional fees and outside services

33.1

34.7

31.0

33.9

28.5

37.4

36.7

47.9

28.2

Amortization of purchased intangibles

55.2

55.5

55.7

55.3

55.2

56.1

56.2

55.9

56.1

Depreciation and amortization

30.1

28.7

28.2

28.1

27.3

26.4

26.5

27.2

Licensing and other fee agreements

87.9

85.9

97.6

84.0

96.6

96.2

81.6

96.6

106.8

Other expense

56.6

58.3

62.3

90.4

54.3

53.2

55.1

85.9

52.5

Operating expenses

528.3

531.9

560.2

578.2

534.3

562.7

565.0

629.1

570.4

Operating Income

959.6

1,000.6

1,024.2

947.1

1,108.0

1,129.3

972.6

1,019.6

1,309.7

Operating Margin

64%

65%

62%

67%

63%

62%

70%

Non-operating Income and Expense

Investment income

1,071.3

1,044.5

1,026.8

936.5

892.7

1,518.4

1,548.7

1,776.7

1,389.3

Interest and other borrowing costs

(39.9)

(40.1)

(40.2)

(40.7)

(41.7)

(44.0)

(43.7)

(43.6)

Equity in net gains (losses) of unconsolidated subsidiaries

87.2

86.4

86.1

91.2

88.2

99.0

96.3

88.2

102.4

Other non-operating income (expense)

(964.8)

(936.9)

(920.0)

(837.5)

(802.4)

(1,372.4)

(1,396.6)

(1,262.4)

(1,246.9)

Non-operating income (expense)

153.8

153.9

152.7

149.5

136.8

201.0

204.4

558.8

201.2

Income before income taxes

1,113.4

1,154.5

1,176.9

1,096.6

1,244.8

1,330.3

1,177.0

1,578.4

1,510.9

Income taxes

258.2

271.3

264.1

222.0

288.6

305.2

269.0

395.5

356.6

Net income

855.2

883.2

912.8

874.6

956.2

1,025.1

908.0

1,182.9

1,154.3

Less: net income (loss) attributable to NCI

Net Income Attributable to CME Group

855.2

883.2

912.8

874.6

956.2

1,025.1

908.0

1,182.9

1,154.3

Net Income Attributable to Common Shareholders of CME Group - Basic(1)

844.4

872.1

901.3

863.7

944.2

1,012.2

896.6

1,168.0

Net Income Attributable to Common Shareholders of CME Group - Diluted(1)

844.4

872.1

901.3

863.7

944.2

1,012.2

896.6

1,168.0

1,154.3

Effective Tax Rate

23.2%

23.5%

22.4%

20.2%

23.2%

22.9%

25.1%

23.6%

Earnings per Share Attributable to Common Shareholders of CME Group:

Basic EPS

2.35

2.43

2.51

2.40

2.63

2.81

2.49

3.25

Diluted EPS

2.35

2.42

2.50

2.40

2.62

2.81

2.49

3.24

3.18

Weighted average number of common stock shares:

Basic Shares

359,258

359,330

359,400

359,568

359,613

359,658

359,686

359,633

359,318

Diluted Shares (2)

359,833

359,869

359,989

360,050

360,227

360,355

360,422

360,233

363,208

Preferred Shares

4,584

The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.

Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026.

CONSOLIDATED STATEMENTS OF NON-GAAP INCOME

QUARTER ENDED

(dollars in millions, except per share data; shares in thousands)

Q124

Q224

Q324

Q424

Q125

Q225

Q325

Q425

Q126

Revenues:

Clearing and transaction fees

1,208.9

1,249.9

1,297.1

1,232.3

1,337.3

1,388.0

1,227.9

1,327.9

1,542.6

Market data and information services

175.4

175.0

178.2

181.6

194.5

198.1

202.5

208.0

224.1

Other Revenue

103.6

106.6

109.2

111.3

110.5

105.9

107.2

112.8

113.4

Total revenues

1,487.9

1,531.5

1,584.5

1,525.2

1,642.3

1,692.0

1,537.6

1,648.7

1,880.1

Expenses:

Compensation and benefits

196.1

201.7

207.5

218.9

207.8

212.5

225.0

232.6

219.5

Technology

59.4

64.1

66.6

65.7

70.9

71.3

75.3

76.6

Professional fees and outside services

33.1

34.7

31.0

33.9

25.2

27.0

28.3

27.9

Amortization of purchased intangibles

Depreciation and amortization

29.3

28.7

28.2

28.0

27.3

26.9

26.4

27.2

Licensing and other fee agreements

87.9

85.9

97.6

84.0

96.6

96.2

81.6

96.6

106.8

Other expense

56.5

58.6

57.9

89.7

52.0

57.7

55.3

84.2

53.7

Operating expenses

462.3

473.7

488.8

520.2

474.6

491.2

486.6

543.4

511.7

Operating Income

1,025.6

1,057.8

1,095.7

1,005.0

1,167.7

1,200.8

1,051.0

1,105.3

1,368.4

Operating Margin

69%

66%

71%

68%

67%

73%

Non-operating Income and Expense

Investment income

1,061.7

1,033.0

1,022.3

943.8

892.3

1,510.7

1,542.1

1,424.4

1,413.0

Interest and other borrowing costs

(39.9)

(40.1)

(40.2)

(40.7)

(41.7)

(44.0)

(43.7)

(43.6)

Equity in net gains (losses) of unconsolidated subsidiaries

100.7

98.8

99.7

104.8

110.4

112.2

101.0

106.4

Other non-operating income (expense)

(964.8)

(936.9)

(920.0)

(837.5)

(802.4)

(1,372.4)

(1,396.6)

(1,262.8)

(1,247.3)

Non-operating income (expense)

157.7

154.8

161.8

170.4

158.6

206.5

213.7

218.9

228.5

Income before income taxes

1,183.3

1,212.6

1,257.5

1,175.4

1,326.3

1,407.3

1,264.7

1,324.2

1,596.9

Income taxes

272.2

280.4

280.5

256.5

306.4

327.9

286.3

313.8

376.8

Net income

911.1

932.2

977.0

918.9

1,019.9

1,079.4

978.4

1,010.4

1,220.1

Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic(1)

899.7

920.4

964.7

907.4

1,007.1

1,065.8

966.1

997.7

1,233.2

Adjusted Net Income Attributable to Common Shareholders of CME Group - Diluted(1)

899.7

920.4

964.7

907.4

1,007.1

1,065.8

966.1

997.7

1,220.1

Effective Tax Rate

23.0%

23.1%

22.3%

21.8%

23.1%

23.3%

22.6%

23.7%

23.6%

Earnings per Share Attributable to Common Shareholders of CME Group:

Basic EPS

2.50

2.56

2.68

2.52

2.80

2.96

2.69

2.77

3.43

Diluted EPS

2.50

2.56

2.68

2.52

2.80

2.96

2.68

2.77

3.36

Weighted average number of common stock shares:

Basic Shares

359,258

359,330

359,400

359,568

359,613

359,658

359,686

359,633

359,318

Diluted Shares(2)

359,833

359,869

359,989

360,050

360,227

360,355

360,422

360,233

363,208

Preferred Shares

4,584

The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.

Preferred shares of 4,584,000 were all converted on March 5, 2026 to Class A Common stock and are included in the Diluted shares for the first quarter of 2026.

Disclaimer

CME Group Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 22, 2026 at 11:23 UTC.